SCHEMBL255537

SCHEMBL255537

CCC[C@@H](C)OCCN(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 4/20 0.38
CHRM1 P11229 4/20 0.38
LMNA P02545 3/20 0.38
ADRA2A P08913 3/20 0.38
SLC6A2 P23975 3/20 0.38
SLC6A4 P31645 3/20 0.38
OPRM1 P35372 3/20 0.38
DRD3 P35462 3/20 0.38
SLC6A3 Q01959 3/20 0.38
CYP2D6 P10635 3/20 0.38
CHRM4 P08173 3/20 0.38
CHRM5 P08912 3/20 0.38
CHRM3 P20309 3/20 0.38
ADRA2B P18089 2/20 0.38
HRH2 P25021 2/20 0.38
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
ADRA1A P35348 2/20 0.38
HRH1 P35367 2/20 0.38
HTR2B P41595 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22021977 1.00 CHRM2 (0.38) CHRM2CHRM1LMNAADRA2ASLC6A2
SCHEMBL12978538 0.81 CHRM2 (0.41) CHRM2CHRM1LMNAADRA2ASLC6A2
SCHEMBL28341029 0.80 MAPT (0.40) CHRM2CHRM1LMNAADRA2ASLC6A2
SCHEMBL24171153 0.79 CHRM2 (0.39) CHRM2CHRM1LMNAADRA2ASLC6A2
SCHEMBL7557809 0.79 CHRM2 (0.39) CHRM2CHRM1LMNAADRA2ASLC6A2
SCHEMBL24070387 0.78 CHRM2 (0.36) CHRM2CHRM1LMNAADRA2ASLC6A2
SCHEMBL9250509 0.78 CHRM2 (0.42) CHRM2CHRM1LMNAADRA2ASLC6A2
SCHEMBL3411855 0.78
SCHEMBL13011270 0.78
SCHEMBL2759866 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017091600-A1 PYRAZOLE ACC INHIBITORS AND USES THEREOF GILEAD APOLLO, LLC (US) 2017-06-01 WO disclosed
WO-2012027960-A1 QUINAZOLINE DERIVATIVES SUBSTITUTED BY ANILINE, PREPARATION METHOD AND USE THEREOF 山东轩竹医药科技有限公司 (CN) 2012-03-08 WO disclosed